Italy Viral Clearance Market

ID: MRFR/HC/50093-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026
Italy Viral Clearance Market Research Report By Method (Viral Removal Method, Viral Inactivation Method, Viral Detection Method), By Application (Blood and Blood Products, Recombinant Proteins, Cellular & Gene Therapy Products, Vaccines, Others) and By End-user (Pharmaceutical and Biotech Industry, Academic Research Institutes, CROs, Others) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Italy Viral Clearance Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)22.0%
2024 Market Size$ 17.6 Million
2025 Market Size$ 21.47 Million
2035 Market Size$ 156.87 Million

Key Players

Merck KGaA
Sartorius AG
Thermo Fisher Scientific Inc.
Charles River Laboratories International Inc.
Lonza Group AG
Boehringer Ingelheim GmbH
Opportunities
  • Increased Regulatory Scrutiny
  • Growing Awareness of Product Safety
  • Rising Demand for Biopharmaceuticals
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Method (USD Million)
      1. 4.1.1 Viral Removal Method
      2. 4.1.2 Viral Inactivation Method
      3. 4.1.3 Viral Detection Method
    2. 4.2 Life Sciences, BY Application (USD Million)
      1. 4.2.1 Blood and Blood Products
      2. 4.2.2 Recombinant Proteins
      3. 4.2.3 Cellular & Gene Therapy Products
      4. 4.2.4 Vaccines
      5. 4.2.5 Others
    3. 4.3 Life Sciences, BY End-user (USD Million)
      1. 4.3.1 Pharmaceutical and Biotech Industry
      2. 4.3.2 Academic Research Institutes
      3. 4.3.3 CROs
      4. 4.3.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Merck KGaA (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Sartorius AG (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Thermo Fisher Scientific Inc. (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Charles River Laboratories International Inc. (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Lonza Group AG (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Boehringer Ingelheim GmbH (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Fujifilm Diosynth Biotechnologies (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 WuXi AppTec (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 ITALY MARKET ANALYSIS BY METHOD
    3. 6.3 ITALY MARKET ANALYSIS BY APPLICATION
    4. 6.4 ITALY MARKET ANALYSIS BY END-USER
    5. 6.5 KEY BUYING CRITERIA OF LIFE SCIENCES
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF LIFE SCIENCES
    8. 6.8 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    10. 6.10 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    11. 6.11 LIFE SCIENCES, BY METHOD, 2024 (% SHARE)
    12. 6.12 LIFE SCIENCES, BY METHOD, 2024 TO 2035 (USD Million)
    13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 LIFE SCIENCES, BY END-USER, 2024 (% SHARE)
    16. 6.16 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY METHOD, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Italy Life Sciences Market Segmentation

Life Sciences By Method (USD Million, 2025-2035)

  • Viral Removal Method
  • Viral Inactivation Method
  • Viral Detection Method

Life Sciences By Application (USD Million, 2025-2035)

  • Blood and Blood Products
  • Recombinant Proteins
  • Cellular & Gene Therapy Products
  • Vaccines
  • Others

Life Sciences By End-user (USD Million, 2025-2035)

  • Pharmaceutical and Biotech Industry
  • Academic Research Institutes
  • CROs
  • Others